Video Latest - ecancer

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland

10 Jan 2014

mCRPC: Challenges and opportunities in a booming area

Dr Nicolas Mottet - University Hospital, Saint-Étienne, France

10 Jan 2014

Predictors of response to mCRPC therapy: where do we stand?

Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands

10 Jan 2014

Managing mCRPC in daily practice: a pragmatic approach

Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK

10 Jan 2014

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion

J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle

10 Jan 2014

Trial results at ASH 2013

Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA

1 Jan 2014

Rituximab maintenance therapy and CLL treatment considerations going forward

Prof Ulrich Jäger - Medical University of Vienna, Austria

1 Jan 2014

Oncotype DX: changing breast cancer treatment

Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA

19 Dec 2013

HER2 positive breast cancer treatment, past and future

Dr Edith Perez - Mayo Clinic, Rochester, USA

19 Dec 2013

A new trial alters therapy landscape in multiple myeloma

Prof Philippe Moreau - University Hospital Hôtel-Dieu, Nantes, France and Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain

19 Dec 2013

PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy

Dr Sibylle Loibl - German Breast Cancer Group

19 Dec 2013

Where to next for the elderly with acute myeloid leukaemia?

Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands

19 Dec 2013

Video